| Literature DB >> 31371631 |
Jia Soon Len1, Wen Shuo Darius Koh1, Shi-Xiong Tan2.
Abstract
Cryopreservation has facilitated advancement of biological research by allowing the storage of cells over prolonged periods of time. While cryopreservation at extremely low temperatures would render cells metabolically inactive, cells suffer insults during the freezing and thawing process. Among such insults, the generation of supra-physiological levels of reactive oxygen species (ROS) could impair cellular functions and survival. Antioxidants are potential additives that were reported to partially or completely reverse freeze-thaw stress-associated impairments. This review aims to discuss the potential sources of cryopreservation-induced ROS and the effectiveness of antioxidant administration when used individually or in combination.Entities:
Keywords: Cryopreservation; antioxidant; oxidative stress; reactive oxygen species
Year: 2019 PMID: 31371631 PMCID: PMC6712439 DOI: 10.1042/BSR20191601
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
Figure 1Metabolism and sources of ROS
(A) Detoxification and metabolism of reactive oxygen/nitrogen species. (B) Sources of ROS, and localization of enzymes that counteracts ROS in the mitochondria, endoplasmic reticulum (ER), peroxisome, cytosol and the extracellular space. SOD1 is localized in both the mitochondria intermembrane space and cytosol, SOD3 is located extracellularly and SOD2 is found exclusively mostly in the mitochondria matrix. Catalase that reduces hydrogen peroxide (H2O2) into H2O is mostly located in the peroxisomes. Glutathione peroxidase (GPx) is found in the mitochondria and cytosol. Peroxiredoxins (Prx) and thioredoxins (Trx) which constitute the Peroxiredoxin–Thioredoxin (Prx/Trx) system can be found in the nucleus, mitochondria, ER, peroxisome and the extracellular environment. Electron transport chain (ETC), Cytochrome P450 family of enzymes (Cyps), xanthene oxidase (XO) and NADPH oxidases (NOX) are potential sources of O2•−, while ERO1 and acetyl CoA oxidases (AcoX) produce H2O2. Nitric oxide synthase (NOS) is a potential source of NO•. Aquaporins (Aqp) facilitate the movement of H2O2 across membranes. Single snowflake indicates ROS detected while two snowflakes indicate an implication with cryopreservation.
Cu2+/Fe3+ (); Cu1+/Fe2+ (); Source of ROS (); Enzyme (); O2•− (); O2 (); H2O (); H2O2 (); •OH (); ONOO− (); NO• (); NO2− (); H+ (); Detected during cryopreservation (); Implicated during cryopreservation ().
Figure 2Effects of different levels of reactive oxygen/nitrogen species on cellular biomolecules
Protein can react with ONOO−, H2O2, NO•, •OH and aldehydes such as 4-Hydroxynonenal (4-HNE) can react with protein side chains (e.g. amino acids such as lysine). The formation of oxo-histidine and disulfide bonds are mostly reversible and mediate redox signaling under mild oxidative stress and may not be deleterious. High level of ROS lead to protein aggregation, denaturation and fragmentation. Mitochondrial/nuclear DNA can react with O2•−, ONOO− and •OH. Mutations and double/single-strand breaks mediated by ROS are minimized by the DNA-Damage Response (DDR). Proteins such as p53, RAD51 and yH2AX are DDR constituents involved in cryopreservation. Severe oxidative stress can overwhelm the DDR, resulting in mutations and double/single strand breaks. Lipids can react with ONOO− and •OH to cause lipid peroxidation and form lipid peroxides (LPOs). LPOs can decompose into aldehydes (Ald) such as 4-HNE and malondialdehyde (MDA). At low levels of ROS, cells are quiescent. Moderate levels of ROS facilitates beneficial redox signaling to modulate cellular survival, growth and division. Overwhelming levels of ROS can initiate cell death.
Antioxidants and their effects on cryopreserved reproductive-associated cells/tissues
| Compound | Cell type | Beneficial effects | No effect/adverse effects | Cryopreservation method |
|---|---|---|---|---|
| 2,4-dinitrophenol (DNP) | Sperm | • Motility (↑) [ | • Motility(N/C) [ | 1 cm styrofoam boat on LN at 10 min [ |
| Ascorbic acid | Sperm | • ROSa (↓) [ | • Motility(N/C) [ | LN vapor phase (6.5-2 cm) at 10–15 min [ |
| Mouse embryos | • Percentage of intact embryos, blastocyst and number of hatching blastocyst (↑) [ | • Fetal development (N/C) [ | Vitrification and slow freezing [ | |
| Antifreeze proteins (AFP) | Oocytes | • ROSa (↓) [ | • Mitochondrial activity (N/C) [ | Vitrification [ |
| BHT | Sperm | • % Motility and viability (↑) [ | • % Sperm with functional intact membrane and GPx activity (N/C) [ | LN vapor phase (4 cm) at 15 min [ |
| Catalase | Sperm | • ROSa (↓) [ | • % cells with intact membrane, H2O2 levelsn, motility, NO• levelsp, free iron concentration and functional membrane (N/C) [ | LN vapor phase (10 cm) at 10 min [ |
| Oocytes | • N.A [ | • Oocyte survival and fertility (N/C) [ | Controlled rate freezing [ | |
| Coenzyme Q | Sperm | • (↑) viability, % sperm with functional membrane and active mitochondria [ | • Slight (↑) or (N/C) ROS k (PI staining was done) [ | LN vapor phase (5 cm) at 12 min [ |
| Egg yolk | Sperm | • N.A [ | • (↓) NO•d [ | LN vapor phase (4 cm) at 10 min [ |
| Glutathione (GSH) | Sperm | • Fertilization rate and % cells with ability to undergo acrosome reaction (↑) [ | • Motility-associated parameters (↓) or (N/C) [ | LN vapor phase (N/I) [ |
| Germ cells enriched with spermatogonial stem cells | • N.A [ | • ATP (N/C) [ | Slow freeze [ | |
| Hemoglobin (Hb) | Oocyte | • Survival and fertility (↑) [ | N.A [ | Controlled freezing [ |
| Hypotaurine/Taurine | Germ cells enriched with spermatogonial stem cells | • Proliferation rate and mitochondrial activity (↑) [ | • Recovery of cells (N/C) [ | Slow-freeze [ |
| Sperm | • DNA fragmentation (↓) [ | • Motility and viability [N/C) [ | LN vapor phase (6.5-2 cm) at 10–15 min [ | |
| Iodixanol | Sperm | • (↑) motility [ | • Acrosomal integrity(N/C) [ | Controlled freezing [ |
| L-carnitine | Sperm | • (↑) viability and motility [ | • DNA oxidatione (N/C) [ | −20°C at 8 min + LN vapor phase at 2 h [ |
| L-proline | Oocyte | • Survival rate (%) (↑) [ | • Developmental parameters. apoptosis levels, spindle recovery (N/C) [ | Vitrification [ |
| Lactoferrin/apotransferrin | Mouse embryos | • (↑) percentage of intact embryos and blastocysts [ | • Hatching blastocyst (N/C) [ | Vitrification or slow freeze [ |
| Sperm | • (↓) Fe3+, NO2− p (Griess reagent system) [ | • H2O2n, membrane intactness, motility (N/C) [ | LN vapor phase at 20 min [ | |
| Melatonin | Sperm | • (↑) total antioxidant capacity, GSH concentration, functional plasma membrane cells, mitochondrial membrane integrity [ | • DNA fragmentation and LDH activity (N/C) [ | LN vapor phase (10 cm) at 1 h [ |
| Oocytes | (↓) ROS levelsu, DNA fragmentation and apoptotic gene expression [ | N.A [ | Vitrification [ | |
| MitoTEMPO | Sperm | • (↑) motility, membrane integrity, sperm vitality, MMP, SOD activity, catalase activity, GPx activity, GPI protein levels [ | • Reversal of some beneficial effects (at 500 μM) [ | LN vapor phase (1–5 cm) at 30 min [ |
| Monothioglycerol (MTG) | Sperm | • Mitochondrial ROSq and total ROSs (↓) [ | • Motility parameters (N/C) [ | LN vapor phase (N/I) [ |
| NG-nitro-L-arginine methyl ester ( | Oocyte | • (↑) fertility and survival (low concentration) [ | • (↓) Fertility and survival (high concentrations) [ | Controlled freezing [ |
| Quercetin | Sperm | • DNA fragmentation (↓) [ | • Progressive motility, acrosome and sperm plasma membrane integrity (N/C) [ | Controlled freezing [ |
| Resveratrol | Sperm | • DNA damage [ | • Progressive motility, acrosome integrity, integrity of sperm plasma membrane (N/C) [ | Slow cool (−20°C) at 10 min followed by LN vapor phase at 2 h [ |
| SOD | Oocyte | • (↑) fertility and survival [ | • Decrease in fertility [ | Controlled rate freezing [ |
| Sperm | • (↑) motility [ | • Motility (N/C) [ | 1 cm styrofoam boat on LN at 10 min [ | |
| Trehalose | Germ cells enriched with spermatogonial stem cells | • (↑) proliferation, recovery of colonies after culture and cell viability [ | • Formation of colonies after transplantation (N/C) [ | Slow freeze [ |
| Testicular tissue | • (↑) cell viability, GSH content and T-AOC [ | • N.A [ | −20°C at 2 h, −80°C at 12 h [ | |
| Vitamin E | Sperm | • (↑) Motility [ | • Viability and motility (N.C) [ | [Controlled rate freezing] 62.3°C/min [ |
| Zinc oxide nanoparticles | Sperm | • DNA damage and lipid peroxidationt (↓) [ | • Sperm motility and ability to undergo the acrosome reaction (N/C) [ | (N/I) Stored at −196°C [ |
| Zinc sulfate | Sperm | • DNA damage (↓) [ | • Motility (N/C) [ | LN vapor phase at 5 min [ |
| Trolox (Vitamin E analog) | Ovarian tissue | Viable follicles (↑) [ | 2°C/min from 20 to −7°C; cooled at 0.3°C/min to −30°C, into LN (−196°C) [ |
Abbreviations: BHT, butylated hydroxytoluene; LN, liquid nitrogen; MDA, malondialdehyde; MMP, mitochondrial membrane potential; N.A, not-applicable; N/C, no changes/no effect. -, no effects have been reported. (↑) and (↓), represent a significant increase or decrease respectively.
∧, denotes cases where effects are context dependent and due to factors such as cell quality and species.
Method employed for detection of ROS and Oxidative biomarkers are denoted by alphabetical superscripts ‘a’ to ‘u’:
a, H2DCFDA.
b, H2DCFDA/Propidium Iodide (Pi).
c, 4,5-diaminofluorescein diacetate (DAF-2DA).
d, DAF-2DA/Ethidium Homodimer -.
e, 8-OHG.
f, BODIPY 581/591 C11.
g, BODIPY 581/591 C11/Propidium Iodide (Pi)-.
h, Bromopyrogallol Red.
i, DHE/Sytox-.
j, DHE.
k, Dihydrorhodamine(DHR) 123/Propidium Iodide (Pi)-.
l, DHR 123.
m, 2,4-dinitrophenylhydrazine (DNPH) assay.
n, Fox2-modified method.
o, Formamidopyrimidine-DNA glycosylase-sensitive comet assay.
p, Griess reagent system.
q, MitoPY1/SYTOX–.
r, PF6-AM/SYTOX.
s, Peroxy Green 1 (PG1).
t, Thiobarbituric acid reactive substances (TBARS) assay.
u, commercial or obscure ROS detection techniques.
Antioxidants and their effects on non-reproductive cell types/tissues
| Compound | Cell type | Beneficial effects | No effect/adverse effects | Cryopreservation method |
|---|---|---|---|---|
| Ascorbic acid | Bone-marrow mononuclear cells | • Clonogenic parameters (↑) [ | • Viability and clonogenic parameters (human model) (N/C) [ | Controlled rate freezing [ |
| Astragalosides | Pancreatic islets | • Restored blood glucose to normal [ | • N.A [ | Slow-freeze [ |
| BHT | Blood cells | • Loss of HUFAs (↓) [ | • N.A [ | Chromatography paper at −20°C [ |
| BHT + ascorbic acid | Hepatocytes | • Post-thaw albumin production (↑) [ | • Induced LDH release (↑) [ | (N/I) stored in −70°C freezer [ |
| Catalase | Mononuclear cells | • Clonogenic parameters (↑) (murine model) [ | • Viability, clonogenic parameters (human model) (N/C) [ | Controlled rate freezing [ |
| Catalase + Trehalose | Hematopoietic cells | • DCF fluorescence intensitya (↓) [ | • N.A [ | Controlled rate freezing [ |
| Consumption of blueberries by PBMC donors | Peripheral blood mononuclear cell | • DNA oxidation (↓)o [ | • DNA damage induced by H2O2 in cryopreserved cells (N/C) [ | Slow freeze [ |
| Deferoxamine | Blood cells | • Loss of HUFA (↓) [ | • N.A [ | Chromatography paper at −20°C [ |
| Glutathione (GSH) | Embryonic stem cells | • ROSa (↓) [ | • N.A [ | (N/I) Stored in −80°C freezer at 24 h [ |
| Embryogenic callus | • Post-thaw survival, GSH, ascorbic acid levels, SOD and peroxidase activity (↑) [ | • At high concentrations, survival (↓) or (N/C) [ | Vitrification [ | |
| Pancreatic islets | • MDAt (↓) [ | • Islet insulin secretion (N/C) [ | Slow freeze [ | |
| Peroxiredoxin | Murine hepatocytes | • Viability (↑) [ | • E-Cadherin cell adhesion proteins (N/C) [ | Slow freeze [ |
| Murine insulinoma | • Viability (↑) [ | • ROSa (N/C) [ | Slow freeze [ | |
| Polyethylene glycol (PEG) | Human embryonic stem cells | • (↓) ROSj [ | • Cell viability (N/C) [ | Slow freeze [ |
| S-Adenosylmethionine | Hepatocytes | • (↑) GSH content and cellular viability [ | • N.A [ | Slow freeze [ |
| Salidroside | Red blood cell | • (↓) protein carboxylationm [ | • Lipid peroxidationt (N/C) (when used with glycerol as a CPA) [ | N.I [ |
| SOD | Bone-marrow mononuclear cells | • N.A [ | • Post-thaw recovery (N/C) [ | Controlled rate freezing [ |
| Trehalose | Dendritic cells | • Preserved cell function and phenotype [ | • N.A [ | Controlled rate freezing [ |
| Hepatocytes | • (↑) albumin secretion, plating efficiency and viability [ | • EROD and ECOD activity, proliferation, LDH, urea levels (N/C) [ | Controlled rate freezing [ | |
| BM-MNC | • (↑) Clonogenic parameters (murine and human models [ | • N.A [ | Slow controlled rate freezing [ | |
| Wheat proteins or Lipocalins | Hepatocytes | • (↑) attachment efficiency and viability [ | • N.A [ | Slow freeze [ |
Abbreviations: AST, aspartate aminotransferase; CFU, colony forming units; DCF, 2′,7′-dichlorofluorescein; BHT, butylated hydroxytoluene; HUFA;highly unsaturated fatty acid; LN, liquid nitrogen; MDA, malondialdehyde; N.A, not-applicable; N/C, no changes/no effect. -, no effects have been reported. (↑) and (↓), represent a significant increase or decrease respectively.
∧, denotes cases where effects are context dependent and due to factors such as cell quality and species.
Method employed for detection of ROS and Oxidative biomarkers are denoted by alphabetical superscripts ‘a’ to ‘u’:
a, H2DCFDA.
b, H2DCFDA/Propidium Iodide (Pi).
c, 4,5-diaminofluorescein diacetate (DAF-2DA).
d, DAF-2DA/Ethidium Homodimer-.
e, 8-OHG.
f, BODIPY 581/591 C11.
g, BODIPY 581/591 C11/Propidium Iodide (Pi)-.
h, Bromopyrogallol Red.
i, DHE/Sytox-.
j, DHE.
k, Dihydrorhodamine (DHR) 123/Propidium Iodide (Pi)-.
l, DHR 123.
m, 2,4-dinitrophenylhydrazine (DNPH) assay.
n, Fox2 modified method.
o, Formamidopyrimidine-DNA glycosylase-sensitive comet assay.
p, Griess reagent system.
q, MitoPY1/SYTOX–.
r, PF6-AM/SYTOX-.
s, Peroxy Green 1 (PG1).
t, Thiobarbituric acid reactive substances (TBARS) assay.
u, Commercial or obscure ROS detection techniques.